CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 185 enrolled
Drug / intervention
Dexcom G6 CGM - Continues Glucose Monitoring sensor system +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03877068
NCT03877068N/ACompleted
CompareCT.gov

Management of Inpatient Hyperglycemia by Continuous Glucose Monitoring in Insulin-treated Patients With Diabetes: Dexcom G6 Intervention Study

Emory University·interventional·Posted Mar 15, 2019·Updated Oct 24, 2023

In Brief

A clinical study evaluating Dexcom G6 CGM - Continues Glucose Monitoring sensor system and POC BG - Point-of-Care Blood Glucose monitoring for Diabetes Mellitus. Completed, enrolled 185 participants across 3 sites.

Detailed Summary

The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour assessment of glucose values compared to Point of Care (POC) testing, during hospitalization and after hospital discharge in general medicine and surgery patients with Type 2 Diabetes (T2D) and Type 1 Diabetes (T1D).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 15, 2019
Enrollment StartJun 26, 2019
Primary CompletionFeb 27, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 7.3 years ago

Interventions

Dexcom G6 CGM - Continues Glucose Monitoring sensor systemdevice

A blinded factory-calibrated continues glucose monitoring sensor system Dexcom G6 will be placed shortly after admission. Two CGM devices will be inserted in all patients - one in the abdomen and one in the arm to also assess differences in blood glucose readings between upper extremity and abdominal insertion sites. Information on CGM readings will be collected daily during the hospital stay up to 10 days using the Dexcom Studio software to download the Dexcom receiver data.

POC BG - Point-of-Care Blood Glucose monitoringother

Standard of care - bedside point-of-care (POC) capillary blood glucose (BG) monitoring will be done before meals and bedtime daily during the hospital stay up to 10 days.